[Federal Register Volume 68, Number 130 (Tuesday, July 8, 2003)]
[Notices]
[Page 40676]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 03-17172]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Disease, Disability, and Injury Prevention and Control Special 
Emphasis Panel: Collection of Specimen Panels for Validation for 
Incidence Assays, Contract Solicitation Number 2003-N-00872

    In accordance with section 10(a)(2) of the Federal Advisory 
Committee Act (Pub. L. 92-463), the Centers for Disease Control and 
Prevention (CDC) announces the following meeting:

    Name: Disease, Disability, and Injury Prevention and Control 
Special Emphasis Panel (SEP): Collection of Specimen Panels for 
Validation for Incidence Assays, Contract Solicitation Number 2003-
N-00872.
    Times and Dates: 7 p.m.-8 p.m., July 24, 2003 (Open); 8 a.m.-
8:30 a.m., July 25, 2003 (Open); 8:30 a.m.-5 p.m., July 25, 2003 
(Closed).
    Place: The Westin Atlanta North at Perimeter Center, 7 Concourse 
Parkway, Atlanta, GA 30328, Telephone 770.395.3900.
    Status: Portions of the meeting will be closed to the public in 
accordance with provisions set forth in Section 552b(c) (4) and (6), 
Title 5 U.S.C., and the Determination of the Director, Management 
Analysis and Services Office, CDC, pursuant to Public Law 92-463.
    Matters To Be Discussed: The meeting will include the review, 
discussion, and evaluation of applications received in response to 
Contract Solicitation Number 2003-N-00872.
    For Further Information Contact: Esther Sumartojo, Ph.D., Deputy 
Associate Director for Science, National Center for HIV, STD, and TB 
Prevention, CDC, 1600 Clifton Road, NE., MS-E07, Atlanta, GA 30333, 
Telephone 404.639.8006.
    The Director, Management Analysis and Services Office, has been 
delegated the authority to sign Federal Register notices pertaining 
to announcements of meetings and other committee management 
activities, for both the CDC and the Agency for Toxic Substances and 
Disease Registry.

    Dated: June 27, 2003.
Alvin Hall,
Director, Management Analysis and Services Office, Centers for Disease 
Control and Prevention (CDC).
[FR Doc. 03-17172 Filed 7-7-03; 8:45 am]
BILLING CODE 4163-18-P